Sun Jia-Bin, Raghavan Sukanya, Sjöling Asa, Lundin Samuel, Holmgren Jan
Department of Microbiology and Immunology, Institute of Biomedicine and Göteborg University Vaccine Research Institute, Sahlgrenska Academy at Göteborg University, 405 30 Göteborg, Sweden.
J Immunol. 2006 Dec 1;177(11):7634-44. doi: 10.4049/jimmunol.177.11.7634.
Oral administration of Ag coupled to cholera toxin B subunit (CTB) efficiently induces peripheral immunological tolerance. We investigated the extent to which this oral tolerance is mediated by CD25+CD4+ regulatory T cells (T(reg)). We found that total T(reg), KJ1-26+ T(reg) and CTLA-4+ T(reg) were all increased in Peyer's patches, mesenteric lymph nodes, and, to a lesser extent, in spleen of mice after intragastric administration of OVA/CTB conjugate, which also increased TGF-beta in serum. This could be abolished by co-administering cholera toxin or by treatment with anti-TGF-beta mAb. CD25+ T(reg), but also CD25-CD4+ T cells from OVA/CTB-treated BALB/c or DO11.10 mice efficiently suppressed effector T cell proliferation and IL-2 production in vitro. Following adoptive transfer, both T cell populations also suppressed OVA-specific T cell and delayed-type hypersensitivity responses in vivo. Foxp3 was strongly expressed by CD25+ T(reg) from OVA/CTB-treated mice, and treatment also markedly expanded CD25+Foxp3+ T(reg). Furthermore, in Rag1(-/-) mice that had adoptively received highly purified Foxp3-CD25-CD4+ OT-II T cells OVA/CTB feeding efficiently induced CD25+ T(reg) cells, which expressed Foxp3 more strongly than naturally developing T(reg) and also had stronger ability to suppress effector OT-II T cell proliferation. A remaining CD25- T cell population, which also became suppressive in response to OVA/CTB treatment, did not express Foxp3. Our results demonstrate that oral tolerance induced by CTB-conjugated Ag is associated with increase in TGF-beta and in both the frequency and suppressive capacity of Foxp3+ and CTLA-4+ CD25+ T(reg) together with the generation of both Foxp3+ and Foxp3-CD25- CD4+ T(reg).
口服与霍乱毒素B亚基(CTB)偶联的抗原(Ag)能有效诱导外周免疫耐受。我们研究了这种口服耐受在多大程度上由CD25⁺CD4⁺调节性T细胞(Treg)介导。我们发现,在给小鼠胃内注射卵清蛋白/CTB偶联物后,派尔集合淋巴结、肠系膜淋巴结以及程度较轻的脾脏中的总Treg、KJ1 - 26⁺Treg和CTLA - 4⁺Treg均增加,血清中的转化生长因子β(TGF - β)也增加。这可通过同时给予霍乱毒素或用抗TGF - β单克隆抗体治疗来消除。来自经卵清蛋白/CTB处理的BALB/c或DO11.10小鼠的CD25⁺Treg以及CD25⁻CD4⁺T细胞在体外均能有效抑制效应T细胞增殖和白细胞介素 - 2的产生。过继转移后,这两种T细胞群体在体内也能抑制卵清蛋白特异性T细胞和迟发型超敏反应。经卵清蛋白/CTB处理的小鼠的CD25⁺Treg强烈表达叉头框蛋白3(Foxp3),处理还显著扩增了CD25⁺Foxp3⁺Treg。此外,在过继接受了高度纯化的Foxp3⁻CD